U.S. flag

An official website of the United States government

NM_024306.5(FA2H):c.21del (p.Ala8fs) AND Spastic paraplegia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 12, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001387014.6

Allele description

NM_024306.5(FA2H):c.21del (p.Ala8fs)

Genes:
LOC130059394:ATAC-STARR-seq lymphoblastoid silent region 7701 [Gene]
FA2H:fatty acid 2-hydroxylase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
16q23.1
Genomic location:
Preferred name:
NM_024306.5(FA2H):c.21del (p.Ala8fs)
HGVS:
  • NC_000016.10:g.74774740del
  • NG_017070.1:g.5097del
  • NM_024306.5:c.21delMANE SELECT
  • NP_077282.3:p.Ala8fs
  • NC_000016.9:g.74808633del
  • NC_000016.9:g.74808638del
Protein change:
A8fs
Links:
dbSNP: rs1962978296
NCBI 1000 Genomes Browser:
rs1962978296
Molecular consequence:
  • NM_024306.5:c.21del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Spastic paraplegia
Identifiers:
MedGen: C0037772; Human Phenotype Ontology: HP:0001258

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001587496Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 12, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).

Kruer MC, Paisán-Ruiz C, Boddaert N, Yoon MY, Hama H, Gregory A, Malandrini A, Woltjer RL, Munnich A, Gobin S, Polster BJ, Palmeri S, Edvardson S, Hardy J, Houlden H, Hayflick SJ.

Ann Neurol. 2010 Nov;68(5):611-8. doi: 10.1002/ana.22122.

PubMed [citation]
PMID:
20853438
PMCID:
PMC6059612

Mutations in FA2H in three Arab families with a clinical spectrum of neurodegeneration and hereditary spastic paraparesis.

Zaki MS, Selim L, Mansour L, Mahmoud IG, Fenstermaker AG, Gabriel SB, Gleeson JG.

Clin Genet. 2015 Jul;88(1):95-7. doi: 10.1111/cge.12516. Epub 2014 Dec 11. No abstract available.

PubMed [citation]
PMID:
25496456
See all PubMed Citations (7)

Details of each submission

From Invitae, SCV001587496.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change creates a premature translational stop signal (p.Ala8Profs*91) in the FA2H gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FA2H are known to be pathogenic (PMID: 20853438, 25496456, 25732363, 26344562). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia (PMID: 27165006, 31135052). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1073882). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024